INCYTE CORP
INCYTE CORP
Share · US45337C1027 · INCY · 896133 (XNAS)
Overview Financial Indicators
68,77 USD
3,41 % 2,27 USD
NASDAQ (XNAS) · Current prices and charts at MoneyPeak
06.06.2025 20:00

Current Prices from INCYTE CORP

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
INCY
USD
06.06.2025 20:00
68,77 USD
67,24 USD
+2,28 %
XLON: London
London
0J9P.L
USD
06.06.2025 15:05
67,97 USD
67,24 USD
+1,09 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % 5,70 % 15,37 % -1,88 % -9,42 % 16,44 % -26,46 %

Company Profile for INCYTE CORP Share

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in various liquid and solid tumor types; and ICLUSIG, a kinase inhibitor to treat chronic myeloid leukemia and philadelphia-chromosome positive acute lymphoblastic leukemia. Its clinical stage products include ruxolitinib, a steroid-refractory chronic graft-versus-host-diseases (GVHD); itacitinib, which is in Phase II/III clinical trial to treat naïve chronic GVHD; and pemigatinib for treating bladder cancer, cholangiocarcinoma, myeloproliferative syndrome, and tumor agnostic. In addition, the company engages in developing Parsaclisib, which is in Phase II clinical trial for follicular lymphoma, marginal zone lymphoma, and mantel cell lymphoma. Additionally, it develops Retifanlimab that is in Phase II clinical trials for MSI-high endometrial cancer, merkel cell carcinoma, and anal cancer, as well as in Phase II clinical trials for patients with non-small cell lung cancer. It has collaboration agreements with Novartis International Pharmaceutical Ltd.; Eli Lilly and Company; Agenus Inc.; Calithera Biosciences, Inc; MacroGenics, Inc.; Merus N.V.; Syros Pharmaceuticals, Inc.; Innovent Biologics, Inc.; Zai Lab Limited; Cellenkos, Inc.; and Nimble Therapeutics, as well as clinical collaborations with MorphoSys AG and Xencor, Inc. to investigate the combination of tafasitamab, plamotamab, and lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma, and relapsed or refractory follicular lymphoma. The company was incorporated in 1991 and is headquartered in Wilmington, Delaware.

Invested Funds

The following funds have invested in: INCYTE CORP invested:

Fund
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. in million
562,22
Percentage (%)
1,32 %
Fund
iShares MSCI World Health Care Sector UCITS ETF USD (Dist)
Vol. in million
659,98
Percentage (%)
0,18 %
Fund
iShares Edge MSCI World Minimum Volatility UCITS ETF EUR Hedged (Acc)
Vol. in million
147,77
Percentage (%)
0,14 %
Fund
iShares Edge MSCI World Minimum Volatility UCITS ETF USD (Dist)
Vol. in million
3,86
Percentage (%)
0,14 %
Fund
iShares Nasdaq 100 UCITS ETF EUR Hedged (Acc)
Vol. in million
214,38
Percentage (%)
0,12 %

Company Data

Name INCYTE CORP
Company Incyte Corporation
Symbol INCY
Website https://www.incyte.com
Primary Exchange XNAS NASDAQ
WKN 896133
ISIN US45337C1027
Asset Class Share
Sector Healthcare
Industry Medical - Pharmaceuticals
CEO Mr. Herve Hoppenot
Market Capitalization 11 Mrd.
Country United States of America
Currency USD
Employees 2,6 T
Address 1801 Augustine Cut-Off, 19803 Wilmington
IPO Date 2018-01-29

Stock Splits

Date Split
01.09.2000 2:1
10.11.1997 2:1

Ticker Symbols

Name Symbol
Frankfurt ICY.F
London 0J9P.L
NASDAQ INCY

More Shares

Investors who INCYTE CORP hold also have the following shares in their portfolio:
ACUITY BRANDS INC
ACUITY BRANDS INC Share
AMGEN INC
AMGEN INC Share
ARCELORMITTAL S.A. ACTIONS NOUVELLES NOMINAT. ON
ARCELORMITTAL S.A. ACTIONS NOUVELLES NOMINAT. ON Share
AUTODESK INC
AUTODESK INC Share
BIOGEN INC
BIOGEN INC Share
CISCO SYSTEMS INC
CISCO SYSTEMS INC Share
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Share
DZ BANK      IS.A2455
DZ BANK IS.A2455 Bond
GUARDANT HEALTH INC
GUARDANT HEALTH INC Share
ILLUMINA INC
ILLUMINA INC Share
INTEL CORP
INTEL CORP Share
MICROSOFT CORP
MICROSOFT CORP Share
VERTEX PHARMACEUTICALS INC
VERTEX PHARMACEUTICALS INC Share
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025